PROTEUS

Their core work

PROTEUS is a French private biotechnology company based in Longjumeau (near Paris) that works in industrial microbiology and bioprocess development. Their H2020 participation reveals two distinct but related competencies: engineering bacteria — specifically Pseudomonas putida — through synthetic biology to convert plastic waste into valuable materials, and applying bioprocess expertise to algae cultivation for the production of high-value bio-based compounds. They join research consortia as a specialist industrial partner, contributing applied microbiology capabilities that translate laboratory-level biology into scalable processes. As a non-SME private company active in EU-funded research, they occupy the relatively rare role of an industry actor with genuine research-stage participation experience.

What they specialise in

How they've shifted over time

PROTEUS's two projects show a clear shift in the biological chassis they work with: their first project (P4SB, from 2015) was anchored in bacterial synthetic biology, specifically engineering Pseudomonas putida for plastic metabolism. Their second project (ABACUS, from 2017) moved toward photosynthetic microorganisms — algae — as a production platform, suggesting growing interest in light-driven bioprocesses. Both projects remain firmly within the bioeconomy space, so the direction is not a pivot but an expansion of their microorganism toolkit from prokaryotic to photosynthetic systems.

PROTEUS appears to be broadening from engineered bacterial systems toward algae-based bioprocessing platforms, tracking industrial bioeconomy trends toward photosynthetic microorganisms as sustainable production hosts.

How they like to work

PROTEUS has participated in both projects exclusively as a partner, never as coordinator, indicating a preference for contributing specialist capabilities within larger consortia rather than leading them. Their 18 unique partners across just 2 projects suggests sizeable consortia (roughly 9 partners per project on average), consistent with the large BBI-JU and RIA frameworks they operate in. This profile suggests they are comfortable as a specialist node in complex multi-partner structures, most likely providing industrial bioprocess credibility alongside more academic partners.

PROTEUS has worked with 18 distinct consortium partners across 6 countries through two projects, reflecting the international composition typical of BBI-JU and Horizon RIA consortia. No repeated-partner pattern is detectable from 2 projects, so their network appears broad rather than concentrated around a fixed core.

What sets them apart

PROTEUS stands out as a private industrial company — not a university or research institute — that participates directly in fundamental bioeconomy research, which is uncommon at the TRL levels these projects typically address. Their combination of bacterial synthetic biology (Pseudomonas-based systems) and algae bioprocessing gives them a cross-platform competency in industrial microbiology that most single-organism specialists lack. For consortium builders in bio-based industries, they offer the industrial application perspective that academic partners often cannot, while still being comfortable operating at research-stage maturity.

Highlights from their portfolio

• P4SB
  This project received PROTEUS's full documented EC funding of EUR 313,625 and tackled one of the more ambitious circular economy challenges of the 2015 era — reprogramming a living bacterium to break down and rebuild plastic — making it their highest-profile and best-funded contribution.
• ABACUS
  Representing a deliberate move into photosynthetic microorganisms, this project signals PROTEUS's ambition to build expertise in algae as an industrial platform, a space that has grown significantly in commercial relevance since the project started in 2017.